The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human safety, imaging and dosimetry of [68Ga]Ga-DPI-4452, a novel CA IX-targeting peptide, in patients with clear cell renal cell carcinoma.
 
Michael S Hofman
Consulting or Advisory Role - Janssen; POINT Biopharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Janssen; Mundipharma
Research Funding - Bayer (Inst); Isotopia (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen; Novartis
 
Ben Tran
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Janssen-Cilag; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; IQvia; Janssen-Cilag; MSD Oncology; Novartis; Pfizer/EMD Serono; Pfizer/EMD Serono; Roche Molecular Diagnostics; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Ipsen; Janssen-Cilag (Inst); Merck Sharp & Dohme; Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Darren R. Feldman
Consulting or Advisory Role - BioNTech; Cigna
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Telix Pharmaceuticals
Other Relationship - UpToDate
 
Anna Pokorska-Bocci
Employment - Debiopharm Group
 
Solen Pichereau
No Relationships to Disclose
 
Jonathan Wessen
Employment - AstraZeneca; Debiopharm Group
Stock and Other Ownership Interests - AstraZeneca
 
Mohammad B. Haskali
Research Funding - Alpha9 theranostics
Patents, Royalties, Other Intellectual Property - Hi hold two active patent applications for discoveries unrelated to this work. One of the patent applications is provisional and the other is a full patent. Both applications are owned by my current and previous institutions. (Inst)
 
Richard Sparks
Consulting or Advisory Role - Debiopharm Group (Inst); Fusion Pharmaceuticals (Inst); Novartis (Inst)
Research Funding - Fusion Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Software Royalty from RADAR (Inst)
 
Olena Vlasyuk
Employment - Debiopharm Group; Sanofi
 
Ivana Galetic
Employment - Advanced Accelerator Applications/Novartis; Debiopharm Group
Leadership - Advanced Accelerator Applications; Debiopharm Group
Stock and Other Ownership Interests - Alcon; Novartis
Patents, Royalties, Other Intellectual Property - Debiopharm patent pending (Inst)